Assistant Professor
Oregon State University
Corvallis, Oregon, United States
Dr. Kaitlin Fogg is an Assistant Professor of Chemical, Biological, and Environmental Engineering at Oregon State University, where her research is focused on developing 3D models of gynecological tissue for drug discovery. She completed her B.S. in Chemical and Biological Engineering from the University of Wisconsin-Madison, her Ph.D. in Biomedical Engineering at the University of California, Davis in 2016, and a postdoctoral fellowship at UW Madison. Her contributions to the field have earned her prestigious recognitions, including a pre-doctoral fellowship from the American Heart Association, a Scientific Scholar award from the Rivkin Center for Ovarian Cancer Research, and recognition as a Shooting Star at the 2018 Cellular and Molecular Bioengineering Conference. Currently, Dr. Fogg's research focuses on engineering complex models of gynecological diseases that are specifically designed for high throughput drug screening. These models serve as a valuable platform for studying signaling dynamics, identifying potential therapeutic targets, and enabling the rapid evaluation of innovating treatment approaches. This research is supported by an NIGMS R35, an NIEHS R01, and an industry partnership with Hewlett-Packard (HP). Additionally, Dr. Fogg is in the seed stage of establishing a biotech company whose mission is to build an expansive library of advanced drug screening platforms tailored specifically for gynecological diseases.
Thursday, October 12, 2023
8:15 AM - 8:30 AM PDT
Biomaterials in Women's Health
Thursday, October 12, 2023
12:30 PM - 2:00 PM PDT
Engineering a 3D in vitro model of cervical dysplasia to enable ethyl cellulose-ethanol ablation
Thursday, October 12, 2023
3:30 PM - 3:45 PM PDT
Navigating the Funding and Visibility Landscape in Women’s Health
Thursday, October 12, 2023
3:00 PM - 4:30 PM PDT
Characterizing the extracellular matrix transcriptome of endometriosis
Friday, October 13, 2023
4:00 PM - 4:15 PM PDT
Development of healthy endometrium and endometriosis models for high throughput phenotypic screening
Friday, October 13, 2023
4:30 PM - 4:45 PM PDT